Interaction of the Phosphotyrosine Interaction/Phosphotyrosine Binding-related Domains of Fe65 with Wild-type and Mutant Alzheimer's β-Amyloid Precursor Proteins-Reference-Cited by-同舟云学术

Interaction of the Phosphotyrosine Interaction/Phosphotyrosine Binding-related Domains of Fe65 with Wild-type and Mutant Alzheimer's β-Amyloid Precursor Proteins

Published:1997-03 Issue:10 Volume:272 Page:6399-6405
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Zambrano Nicola,Buxbaum Joseph D.,Minopoli Giuseppina,Fiore Francesca,De Candia Paola,De Renzis Stefano,Faraonio Raffaella,Sabo Shasta,Cheetham Jim,Sudol Marius,Russo Tommaso

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference33 articles.

1. The molecular pathology of Alzheimer's disease

2. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go

3. APP-BP1, a Novel Protein That Binds to the Carboxyl-terminal Region of the Amyloid Precursor Protein

4. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein

5. The Regions of the Fe65 Protein Homologous to the Phosphotyrosine Interaction/Phosphotyrosine Binding Domain of Shc Bind the Intracellular Domain of the Alzheimer's Amyloid Precursor Protein

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha-secretase dependent nuclear localization of the amyloid-β precursor protein-binding protein Fe65 promotes DNA repair;Molecular and Cellular Neuroscience;2023-12

2. Vav2 is a novel APP-interacting protein that regulates APP protein level;Scientific Reports;2022-07-26

3. Physiology and pharmacology of amyloid precursor protein;Pharmacology & Therapeutics;2022-07

4. Resurgence of phosphotyrosine binding domains: Structural and functional properties essential for understanding disease pathogenesis;Biochimica et Biophysica Acta (BBA) - General Subjects;2021-11

5. FE65 in breast cancer and its clinicopathological significance;Breast Cancer;2021-09-08